BioForward Wisconsin CEO to Retire
BioForward Wisconsin CEO Lisa Johnson is set to retire at the end of 2026, the organization announced recently. Johnson has been the CEO for the past 11 years and played…
BioForward Wisconsin CEO Lisa Johnson is set to retire at the end of 2026, the organization announced recently. Johnson has been the CEO for the past 11 years and played…
Cellectar Biosciences announced updated and mature 12-month follow-up data from its Phase 2b CLOVER WaM clinical trial evaluating iopofosine I 131 in patients with relapsed or refractory Waldenstrom macroglobulinemia, the…
Elephas is collaborating with Mithrl, an AI company focused on accelerating research through its Scientific Decision Engine (SDE), the company announced recently. “Partnering with Mithrl enables us to more fully…
Northstar Medical Radioisotopes received notice of U.S. Food & Drug Administration (FDA) acceptance of its Type II Drug Master File (DMR) submission for the company’s no-carrier-added (n.c.a.) Actinium-225 (Ac-225), the…
SHINE has received a conditional commitment for a loan of $263 million from the U.S. Department of Energy’s (DOE) Office of Energy Dominance Financing, the company announced today. According to…
SHINE Technologies has entered a supply agreement with C-Ray Therapeutics, a global radiopharmaceutical CRDMO, the company announced recently. According to a release, C-Ray will supply SHINE’s n.c.a. Lu-177 to Chinese…
BrainXell is launching its human induced pluripotent stem cell (iPSC)-derived sensory neurons, the company announced recently. According to a release, the iPSC-derived sensory neurons are a scalable human cellular platform…
SHINE Technologies has raised $240 million in equity funding, the company announced recently. The round was led by NantWorks with additional participation from Fidelity Management & Research Company, Sumitomo Corporation of…
Elephas Biosciences Corporation is partnering with the University of Louisville on a new research opportunity that will evaluate the impact of a combination therapy of surgical intervention and immunotherapy in…
NorthStar Medical Radioisotopes has entered into a strategic supply agreement with BIOEMTECH, a developer of high-resolution PET and SPECT imaging systems for preclinical and translational research, the company announced today….